Ingevity Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

$NGVT
Major Chemicals
Industrials
Get the next $NGVT alert in real time by email
ngvt-20241216
falseIngevity Corp000165347700016534772024-12-162024-12-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________ 
FORM 8-K
_______________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

December 16, 2024
Date of Report (date of earliest event reported)
__________________________________________________________________________
ingevitylogorgba11.jpg
INGEVITY CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware001-3758647-4027764
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
4920 O'Hear Avenue Suite 400North CharlestonSouth Carolina29405
(Address of principal executive offices) (Zip code)


Registrant’s telephone number, including area code: 843-740-2300

Not Applicable
(Former name or former address, if changed since last report)
_____________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock ($0.01 par value)NGVTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Acto
_____________________________________________________________________________________________________



ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On December 16, 2024, upon the recommendation of the Nominating and Governance Committee of the Board of Directors (the “Board”) of Ingevity Corporation (the “Company”), the Board approved: (i) an increase in the size of the Board to nine members; and (ii) the election of Mr. J. Kevin Willis to fill the vacancy created by the expansion of the Board.
Mr. Willis will serve until the Company’s 2025 Annual Meeting of Stockholders and until his successor shall have been duly elected and qualified. Mr. Willis will serve on the Board’s Audit Committee and Sustainability and Safety Committee.
There are no arrangements or understandings between Mr. Willis and any other person pursuant to which Mr. Willis was elected as a director, nor have there been any transactions involving Mr. Willis that would be required to be reported under Item 404(a) of Regulation S-K.
Mr. Willis will receive compensation in accordance with the Company’s non-employee director compensation practices described under the “Director Compensation” section of the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 11, 2024, as amended. His compensation will be pro-rated for the 2024-2025 term.
A copy of the press release announcing the election of Mr. Willis to the Board is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.
Exhibit No.Description of Exhibit
Press release dated December 16, 2024
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INGEVITY CORPORATION
(Registrant)
By:/S/ RYAN C. FISHER
Ryan C. Fisher
Senior Vice President, General Counsel and Secretary
Date: December 16, 2024

Get the next $NGVT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NGVT

DatePrice TargetRatingAnalyst
8/7/2024$58.00Market Perform → Market Outperform
CJS Securities
4/22/2024$52.00 → $62.00Hold → Buy
Jefferies
11/6/2023$49.00Market Outperform → Market Perform
CJS Securities
10/3/2023$62.00 → $53.00Buy → Hold
Loop Capital
8/7/2023$71.00 → $60.00Outperform → Market Perform
BMO Capital Markets
7/27/2023$64.00 → $75.00Hold → Buy
Loop Capital
5/5/2023$92.00 → $64.00Buy → Hold
Loop Capital
2/2/2023$81.00 → $100.00Hold → Buy
Loop Capital
More analyst ratings

$NGVT
Press Releases

Fastest customizable press release news feed in the world

See more
  • Ingevity reports fourth quarter and full year 2024 financial results

    Fourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen

    $NGVT
    Major Chemicals
    Industrials
  • Ingevity named as one of America's Most Responsible Companies of 2025 by Newsweek

    Ingevity (NYSE:NGVT) today announced it has been named as one of "America's Most Responsible Companies of 2025" by Newsweek magazine for the third consecutive year. This prestigious award recognizes the top 600 publicly traded companies headquartered in the United States for their commitment to making a positive global impact. "We are honored to be recognized by Newsweek as one of America's Most Responsible Companies for 2025," said Luis Fernandez-Moreno, Ingevity interim president and CEO. "Ingevity was founded on products that contribute to safeguarding our environment, and this achievement highlights our company's further commitments to pursuing excellence in governance, prioritizing o

    $NGVT
    Major Chemicals
    Industrials
  • Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results

    Exiting of targeted product line expected to further strengthen the Performance Chemicals segment and improve Ingevity's overall earnings and cash flow profile Evaluating additional potential actions to maximize shareholder value Full year 2024 Net sales expected to be approximately $1.40 billion; Adjusted EBITDA of approximately $360 million Ingevity Corporation (NYSE:NGVT) today announced that it is exploring strategic alternatives for the company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. Ingevity noted that this process includes all Industrial Specialties pine chemical-based chemistri

    $NGVT
    Major Chemicals
    Industrials

$NGVT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$NGVT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$NGVT
SEC Filings

See more

$NGVT
Leadership Updates

Live Leadership Updates

See more
  • Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO

    Ingevity Corporation (NYSE:NGVT) today announced that John Fortson has departed as president and chief executive officer and from the board of directors of the company, effective as of October 2, 2024. The board of directors has appointed current board director, Luis Fernandez-Moreno as interim president and chief executive officer while it conducts a search for a permanent replacement. "On behalf of the entire board, I want to thank John for his leadership and dedication to Ingevity over the past nine years," said Jean Blackwell, chair of the board of directors. "Under John's guidance, Ingevity successfully transitioned into a standalone public company, expanded its global footprint and e

    $NGVT
    Major Chemicals
    Industrials
  • Ingevity names new general counsel and chief human resources officer to executive leadership team

    Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. "We are excited to add Ryan and Terry to our executive leadership team," said Ingevity president and CEO, John Fortson. "Both leaders bring extensive experience, with successful track records of leading companies through business growth and expansion. I am confident that their contributions will be instrumental in driving our continued success and innovation." Fisher has held various leadership positions during his 18-year tenure with Ingevity and its predecessors. Most recent

    $NGVT
    Major Chemicals
    Industrials
  • Allegion Appoints Stacy Cozad as New General Counsel

    Allegion plc (NYSE:ALLE), a leading global security products and solutions provider, has appointed Stacy Cozad as senior vice president, general counsel and corporate secretary, effective Aug. 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240701071652/en/Stacy Cozad (Photo: Business Wire) In this role, Cozad will have responsibility for Allegion's global legal affairs, trade compliance, enterprise risk management and corporate communications functions. She will succeed Jeff Braun, who has announced plans to retire on Dec. 31, 2024, and will serve as an advisor during the transition. Cozad has nearly 30 years of exper

    $ALLE
    $NGVT
    $SPR
    Diversified Commercial Services
    Consumer Discretionary
    Major Chemicals
    Industrials

$NGVT
Financials

Live finance-specific insights

See more
  • Ingevity reports fourth quarter and full year 2024 financial results

    Fourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen

    $NGVT
    Major Chemicals
    Industrials
  • Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results

    Exiting of targeted product line expected to further strengthen the Performance Chemicals segment and improve Ingevity's overall earnings and cash flow profile Evaluating additional potential actions to maximize shareholder value Full year 2024 Net sales expected to be approximately $1.40 billion; Adjusted EBITDA of approximately $360 million Ingevity Corporation (NYSE:NGVT) today announced that it is exploring strategic alternatives for the company's Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. Ingevity noted that this process includes all Industrial Specialties pine chemical-based chemistri

    $NGVT
    Major Chemicals
    Industrials
  • Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth-quarter and full year 2024 earnings after the stock market closes on Tuesday, February 18, 2025. The company will host a live webcast on Wednesday, February 19, at 10:00 a.m. (Eastern) to discuss Ingevity's fourth-quarter and full year 2024 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 068901. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at

    $NGVT
    Major Chemicals
    Industrials

$NGVT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more